Hangzhou Biotest Biotech Co.,Ltd. (SHA:688767)
China · Delayed Price · Currency is CNY 35.85
+1.08 (3.11%)
Apr 21, 2026, 3:00 PM CST
Hangzhou Biotest Biotech Market Cap
Hangzhou Biotest Biotech has a market cap or net worth of 5.25 billion as of April 21, 2026. Its market cap has increased by 32.22% in one year.
Market Cap
5.25B
Enterprise Value
3.72B
Revenue
448.37M
Ranking
n/a
PE Ratio
112.03
Stock Price
35.85
Market Cap Chart
Since September 8, 2021, Hangzhou Biotest Biotech's market cap has decreased from 8.23B to 5.25B, a decrease of -36.24%. That is a compound annual growth rate of -9.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 5.09B | -7.97% |
| Dec 31, 2025 | 5.53B | 60.13% |
| Dec 31, 2024 | 3.45B | 6.92% |
| Dec 29, 2023 | 3.23B | -34.48% |
| Dec 30, 2022 | 4.93B | -33.91% |
| Dec 31, 2021 | 7.46B | -9.37% |
| Sep 8, 2021 | 8.23B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novogene | 5.87B |
| Innovita Biological Technology | 5.85B |
| Wuhan Hvsen Biotechnology | 5.68B |
| ChemPartner PharmaTech | 5.52B |
| PharmaResources (Shanghai) | 5.51B |
| Assure Tech (Hangzhou) | 4.89B |
| Jiangsu Bioperfectus Technologies | 4.78B |
| Beijing Bohui Innovation Biotechnology Group | 4.66B |